Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

Propanc Health Group Corp. (PPCH) Releases Study Results for Lead Product, Confirms Potential to Fight Certain Cancer Types

Propanc Health Group Corp. (OTCQB: PPCH) is an emerging healthcare company focused on the development of new and proprietary treatments for cancer patients suffering from solid tumors, such as those resulting from pancreatic, ovarian, and colorectal cancers. The company recently announced results from studies for its lead product, PRP, confirming a synergistic response to a […]

Nutra Pharma Corporation (NPHC) Expanding Its Reach in the Pharmaceutical Space

Nutra Pharma Corporation (OTCQB: NPHC) is actively pursuing growth plans that will bolster its core business while expanding its reach into vital commercial markets. A versatile biotechnology company, Nutra Pharma markets Nyloxin and Pet Pain-Away (homeopathic drugs that treat moderate-to-severe chronic pain in humans and pets, respectively) to the over-the-counter pain management market. Millions of […]

Moxian, Inc. (MOXC) Drives Consumers toward Merchants through Advertisements, Incentives, and a Fun Social Media Platform

Based in Shenzhen, China, Moxian, Inc. (OTCQB: MOXC) provides social marketing and other promotional platforms for companies who want to showcase their businesses through social media. These companies are able to see consumer trends through compiled data from Moxian’s proprietary Social Customer Relationship Management (SCRM) system. Businesses can then run advertising campaigns that target specific […]

International Stem Cell Corp. (ISCO): Benefits of Stem Cells Outlined in Israel/California Collaboration

In a recent article on the Jewish Journal website (http://dtn.fm/DhxK8), doctors, dignitaries and officials representing Israel and California convened at Cedars-Sinai Medical Center on February 8, 2016, to witness the signing of an agreement between Israel’s Ministry of Science and the California Institute for Regenerative Medicine (CIRM) to collaborate on stem cell research. It follows […]

Content Checked Holdings, Inc. (CNCK) Supports Discerning Diets

Whether in the kitchen or on the go, Content Checked Holdings, Inc. (OTCQB: CNCK) is empowering individuals and families and enhancing their quality of life. A rising software developer, Content Checked has created a series of reliable, efficient and fast mobile apps that assist consumers in making informed food purchasing decisions based on their dietary […]

Immune Therapeutics, Inc. (IMUN) Expands Board of Directors

Before the opening bell, Immune Therapeutics, Inc. (OTCQB: IMUN) announced the appointment of two new members to its board of directors: Dr. Clifford A. Selsky and Paul Akin. Akin brings a wealth of financial experience developed across his prior operating and board roles to the Immune Therapeutics board, while Selsky offers a critical perspective as […]

Elio Motors, Inc. (ELIO) Has a Clearly-Focused Strategy to Dominate Underserved Segment of Car Market amid Big Short 2.0 Auto Loans

In an age of subprime 2.0, where the next Big Short is looking more and more like auto loans (http://dtn.fm/XfWR0) as delinquencies hit a six-year high of around five percent (the highest level since September 2009), the idea of an American-made, ultra-high-mileage two-seater, sporting an amazing 84 MPG highway and going for a targeted sticker […]

 

From Our Blog

Soligenix Inc. (NASDAQ: SNGX) Strengthens Rare Disease Pipeline Program Through UK Regulatory Innovation Designation

March 20, 2026

Regulatory recognition from international health authorities can significantly shape the trajectory of emerging therapies worldwide, particularly in rare disease development where clinical pathways are often complex and resource intensive. Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company focused on developing and commercializing treatments for rare diseases and unmet medical needs, recently received such recognition as its […]

Rotate your device 90° to view site.